Kabra Drugs Ltd.
|
Cash Flow
|
|
You can view the
Cash Flow
for the last 5 years.
Market Cap. (Rs.)
|
47.68 Cr.
|
P/BV
|
1.93
|
Book Value (Rs.)
|
10.40
|
52 Week High/Low (Rs.)
|
23/8
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | -1.09 | -0.74 | -0.34 | -0.19 | -0.18 |
| | | | | |
Net CashFlow From Operating Activities | -4.71 | -0.21 | -0.35 | -0.13 | -0.25 |
Net Cash Used In Investing Activities | -0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash Used From Financing Activities | 23.39 | 2.88 | 0.36 | 0.13 | 0.25 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | 18.63 | 2.67 | 0.00 | -0.01 | 0.00 |
Cash And Cash Equivalents Begin of Year | 2.67 | 0.00 | 0.00 | 0.01 | 0.01 |
Cash And Cash Equivalents End Of Year | 21.30 | 2.67 | 0.00 | 0.00 | 0.01 |